Endless RNA Creator Secures $440 Million to Build Gigabase Factory

Endless RNA Creator Secures $440 Million to Build Gigabase Factory

Source: 
BioSpace
snippet: 

Back in May 2021, Flagship Pioneering announced plans to develop as many as 100 Endless RNA (eRNA) products and drug programs over the next decade from the launch of Laronde, a platform company dedicated to achieving this goal. Three months later, Laronde has managed to secure as much as $440 million from a Series B financing round to support its mission further.